Table 1.

Treatment groups, drug concentrations, and number of PCOs ($n$) assessed for P1 and P2 lines.

Treatment group	Drug class	Mechanism of action	Concentration	$n$ (P1)	$n$ (P2)
Sodium cyanide49	Metabolic inhibitor	Mitochondrial complex IV inhibition	$4\mathrm{mmol}/\mathrm{L}$	14	11
2DG50	Metabolic inhibitor	Glucose-6-phosphate production inhibitor	$10\mathrm{mmol}/\mathrm{L}$	13	8
Cisplatin51	Chemotherapy	DNA replication inhibition	$33\mu \mathrm{mol}/\mathrm{L}$	7	4
Paclitaxel52	Chemotherapy	Microtubule stabilization	$0.5\mu \mathrm{mol}/\mathrm{L}$	4	6
Control (no treatment)	n/a	n/a	n/a	10	6
			Total	48	35